Hurricane Milton in 2024 was a stark reminder that reliable backup power is not a luxury but a necessity in Tampa. With hurricane season running June through November and daily summer thunderstorms, ...

When a December Chinook slammed the Front Range in 2025, and Xcel Energy cut power to over 120,000 customers, Denver homeowners sat in the dark for up to three days. Events like that have made standby ...

AI video generators help you turn your prompts into believable videos, complete with audio. We've tested all the top services to help you choose the one that does the best job with the fewest tweaks.

We've tested the top AI image generation apps to help you find the one that produces the best results for the lowest price. I’ve been writing about consumer technology and video games for more than a ...

Generate Biomedicines, Inc. is a clinical-stage biotechnology company focused on using artificial intelligence and machine learning to create protein-based medicines. The company operates in the ...

AI has taken the world by storm over the last few years, with millions of users writing prompts on platforms like ChatGPT to generate content, images, and yes videos. Still, some of these platforms ...

Driving an RV lets you bring the comforts of home along on your road trip, but having a portable generator is essential. It powers your electric appliances and charges electronics, like your phone and ...

Rebar, a startup building an AI operating system for commercial HVAC suppliers, has raised $14 million in a Series A funding round, it tells Crunchbase News exclusively. Founded in October 2024, Rebar ...

Generate:Biomedicines has hit the public markets as the world begins to question the usefulness of AI technology. CEO Mike Nally says biology is the key to unlocking the technology’s full potential.

Feb 27 (Reuters) - Flagship-backed Generate Biomedicines' shares fell more than 6% in their Nasdaq debut on Friday, giving the drug developer a valuation of $1.91 billion, as lingering market ...

Despite wide availability of biologic drugs for asthma, use of these injectable medicines remains low — patients just dislike frequent injections. Generate Biomedicine’s lead drug candidate could ...